[1] |
Jou A, Hess J.Epidemiology and Molecular Biology of Head and Neck Cancer[J].Oncol Res Treat, 2017, 40(6):328-332
|
[2] |
Solomon B, Young RJ, Rischin D.Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments[J].Semin Cancer Biol, 2018, 52(Pt 2):228-240
|
[3] |
Schuler PJ, Laban S, Doescher J, et al.Novel Treatment Options in Head and Neck Cancer[J].Oncol Res Treat, 2017, 40(6):342-346
|
[4] |
Feng M, Xiong G, Cao Z, et al.PD-1/PD-L1 and immunotherapy for pancreatic cancer [J]. Cancer Lett, 2017, 407:57-65.
|
[5] |
Mansoori B, Mohammadi A, Shirjang S, et al.MicroRNAs in the Diagnosis and Treatment of Cancer[J].Immunol Invest, 2017, 46(8):880-897
|
[6] |
Mohr AM, Mott JL.Overview of microRNA biology[J].Semin Liver Dis, 2015, 35(1):3-11
|
[7] |
Salazar C, Calvopi?a D, Punyadeera C.miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas[J].Expert Rev Mol Diagn, 2014, 14(8):1033-1040
|
[8] |
Masood Y, Kqueen CY, Rajadurai P.Role of miRNA in head and neck squamous cell carcinoma[J].Expert Rev Anticancer Ther, 2015, 15(2):183-197
|
[9] |
Koshizuka K, Hanazawa T, Fukumoto I, et al.The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma[J].J Hum Genet, 2017, 62(1):3-13
|
[10] |
Yang CX, Sedhom W, Song J, et al.The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma [J]. Cancers (Basel), 2019, 11(3).
|
[11] |
Janiszewska J, Szaumkessel M, Szyfter K.microRNAs are important players in head and neck carcinoma: a review[J].Crit Rev Oncol Hematol, 2013, 88(3):716-728
|
[12] |
Wang Y, Chen J, Chen X, et al.MiR-34a suppresses HNSCC growth through modulating cell cycle arrest and senescence[J].Neoplasma, 2017, 64(4):543-553
|
[13] |
Sun X, Xiao D, Xu T, et al.miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5[J].Future Oncol, 2016, 12(23):2701-2712
|
[14] |
El Baroudi M, Machiels JP, Schmitz S.Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck [J].Cancer Biol Ther. 2017, 18(10):775-782.
|
[15] |
Lamperska KM, Kolenda T, Teresiak A, et al.Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics[J].PLoS One, 2017, 12(6):e0180265-
|
[16] |
Jung AC, Job S, Ledrappier S, et al.A poor prognosis subtype of HNSCC is consistently observed across methylome,transcriptome,and miRNome analysis[J].Clin Cancer Res, 2013, 19(15):4174-4184
|
[17] |
Baltruskeviciene E, Schveigert D, Stankevicius V, et al.Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding[J].BMC Cancer, 2017, 17(1):607-
|
[18] |
He M, Zhan M, Chen W, et al.MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer[J].Cell PhysiolBiochem, 2017, 42(5):2078-2092
|
[19] |
Xu W, Yang Z, Lu N.A new role for the PI3KAkt signaling pathway in the epithelial-mesenchymal transition[J].Cell AdhMigr, 2015, 9(4):317-324
|